サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1544015

トランスフェクション試薬と装置の世界市場

Transfection Reagents and Equipment

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
トランスフェクション試薬と装置の世界市場
出版日: 2024年08月29日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

トランスフェクション試薬と装置の世界市場は2030年までに18億米ドルに達する見込み

2023年に12億米ドルと推定されたトランスフェクション試薬と装置の世界市場は、2030年には18億米ドルに達し、分析期間2023-2030年のCAGRは6.1%で成長すると予測されます。本レポートで分析したセグメントの1つであるトランスフェクション試薬は、CAGR 6.6%を記録し、分析期間終了までに12億米ドルに達すると予測されます。トランスフェクション機器セグメントの成長率は、分析期間中CAGR 5.3％と推定されます。

米国市場は3億2,410万米ドルと推定、中国はCAGR5.7％で成長予測

米国のトランスフェクション試薬と装置市場は、2023年に3億2,410万米ドルと推定されます。世界第2位の経済大国である中国は、2023-2030年のCAGRを5.7%として、2030年までに2億8,270万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.3%と5.2%と予測されています。欧州では、ドイツがCAGR 4.7%で成長すると予測されています。

世界のトランスフェクション試薬と装置市場- 主要動向と促進要因のまとめ

トランスフェクション試薬と装置とは何か、なぜ必要なのか？

トランスフェクション試薬と装置は、分子生物学や遺伝子研究において、核酸（DNAまたはRNA）を細胞に導入するために使用される重要なツールです。これらのツールは、遺伝子発現研究、タンパク質生産、遺伝子組み換え生物の開発など、様々な用途に不可欠です。脂質、ポリマー、エレクトロポレーション溶液などのトランスフェクション試薬は、核酸の細胞内への取り込みと発現を促進することにより、核酸の細胞内への導入を容易にします。エレクトロポレーターやマイクロインジェクターなどのトランスフェクション機器は、効率的で信頼性の高いトランスフェクションを実現するために必要な技術を提供します。これらのツールは、遺伝子機能、疾病メカニズム、新規治療薬の開発についての理解を深めるための基礎となるものです。

トランスフェクション試薬と装置は遺伝子研究をどのように強化しますか？

トランスフェクション試薬と装置は、細胞に遺伝物質を導入するための信頼性の高い効率的な方法を提供することにより、遺伝子研究を促進します。これらのツールにより、研究者は遺伝子の機能や制御の研究、疾患のモデル化、遺伝子に基づく治療法の開発を行うことができます。高度なトランスフェクション試薬は、トランスフェクション効率を向上させ、細胞毒性を減らし、大きな核酸や複雑な核酸の送達を可能にするために開発されてきました。例えばエレクトロポレーション装置は、電気パルスを使って細胞膜に一時的な孔を開け、核酸が高効率で細胞内に入ることを可能にします。トランスフェクション・プロセスを最適化することで、これらの試薬や機器は正確で再現性の高い実験を容易にし、科学的発見や革新的治療の開発を加速します。

トランスフェクション試薬と装置の需要が増加しているのはなぜですか？

トランスフェクション試薬と装置の需要は、いくつかの重要な要因により増加しています。遺伝子機能の解明と遺伝子治療の開発による遺伝子およびゲノム研究の増加は、高度なトランスフェクションツールの必要性を煽っています。CRISPR-Cas9やその他の遺伝子編集技術を含むバイオテクノロジーの進歩は、その成功のために効率的なトランスフェクション法を必要とします。個別化医療や標的治療への注目の高まりも、新たな治療法を開発・試験するための信頼性の高いトランスフェクション・システムに対する需要を後押ししています。さらに、バイオテクノロジーおよび製薬業界の成長と研究開発資金の増加が、トランスフェクション試薬と装置市場の拡大を支えています。効率的で再現性の高いトランスフェクション法が学術研究および産業研究に求められていることも、トランスフェクション法の普及を後押ししています。

トランスフェクション試薬と装置市場の成長を促進する要因は？

トランスフェクション試薬と装置市場の成長は、いくつかの要因によって牽引されています。遺伝子研究や遺伝子治療開発への注目の高まりにより、これらの研究を促進する高度なトランスフェクションツールが必要とされています。送達方法の改善や細胞毒性の低減など、トランスフェクション試薬と装置の技術的進歩は、その効率性と信頼性を高め、採用を促進しています。バイオテクノロジーと製薬セクターの拡大と研究資金の増加が市場の成長を支えています。個別化医療の台頭や標的治療の必要性も、効率的なトランスフェクション・システムに対する需要を後押ししています。さらに、CRISPR-Cas9のような遺伝子編集技術の応用が拡大しているため、信頼性の高いトランスフェクション法が必要とされ、市場の成長をさらに後押ししています。遺伝性疾患やがんの新規治療法の開発に重点が置かれていることは、医学研究や治療開発の進展におけるトランスフェクション試薬と装置の重要性を強調しています。

調査対象企業の例（注目の42社）

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Life Technologies Corporation
  • Lonza Group AG
  • MilliporeSigma
  • PolyPlus Battery Company（PPBC）
  • Promega Corporation
  • Qiagen NV
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP15289

Global Transfection Reagents and Equipment Market to Reach US$1.8 Billion by 2030

The global market for Transfection Reagents and Equipment estimated at US$1.2 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Transfection Reagents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Transfection Equipment segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$324.1 Million While China is Forecast to Grow at 5.7% CAGR

The Transfection Reagents and Equipment market in the U.S. is estimated at US$324.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$282.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.3% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Transfection Reagents and Equipment Market - Key Trends & Drivers Summarized

What are Transfection Reagents and Equipment and Why are They Essential?

Transfection Reagents and Equipment are crucial tools used in molecular biology and genetic research to introduce nucleic acids (DNA or RNA) into cells. These tools are essential for various applications, including gene expression studies, protein production, and the development of genetically modified organisms. Transfection reagents, such as lipids, polymers, and electroporation solutions, facilitate the delivery of nucleic acids into cells by promoting their uptake and expression. Transfection equipment, including electroporators and microinjectors, provides the necessary technology to achieve efficient and reliable transfection. These tools are fundamental for advancing our understanding of gene function, disease mechanisms, and the development of novel therapeutics.

How Do Transfection Reagents and Equipment Enhance Genetic Research?

Transfection Reagents and Equipment enhance genetic research by providing reliable and efficient methods for introducing genetic material into cells. These tools enable researchers to study gene function and regulation, model diseases, and develop gene-based therapies. Advanced transfection reagents have been developed to improve transfection efficiency, reduce cytotoxicity, and enable the delivery of large or complex nucleic acids. Electroporation equipment, for instance, uses electrical pulses to create temporary pores in cell membranes, allowing nucleic acids to enter cells with high efficiency. By optimizing the transfection process, these reagents and equipment facilitate accurate and reproducible experiments, accelerating scientific discoveries and the development of innovative treatments.

Why is the Demand for Transfection Reagents and Equipment Increasing?

The demand for Transfection Reagents and Equipment is increasing due to several critical factors. The rise in genetic and genomic research, driven by the growing understanding of gene functions and the development of gene therapies, fuels the need for advanced transfection tools. Advances in biotechnology, including CRISPR-Cas9 and other gene-editing technologies, require efficient transfection methods for successful implementation. The increasing focus on personalized medicine and targeted therapies also drives the demand for reliable transfection systems to develop and test new treatments. Additionally, the growth of the biotechnology and pharmaceutical industries, along with increased funding for research and development, supports the expanding market for transfection reagents and equipment. The need for efficient and reproducible transfection methods in academic and industrial research further contributes to their widespread adoption.

What Factors are Driving the Growth of the Transfection Reagents and Equipment Market?

The growth in the Transfection Reagents and Equipment market is driven by several factors. The increasing focus on genetic research and the development of gene therapies necessitate advanced transfection tools to facilitate these studies. Technological advancements in transfection reagents and equipment, such as improved delivery methods and reduced cytotoxicity, enhance their efficiency and reliability, driving their adoption. The expansion of the biotechnology and pharmaceutical sectors, coupled with increased research funding, supports market growth. The rise of personalized medicine and the need for targeted therapies also propel the demand for efficient transfection systems. Additionally, the growing application of gene editing technologies like CRISPR-Cas9 requires reliable transfection methods, further boosting market growth. The emphasis on developing novel treatments for genetic disorders and cancers underscores the importance of transfection reagents and equipment in advancing medical research and therapeutic development.

Select Competitors (Total 42 Featured) -

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Life Technologies Corporation
  • Lonza Group AG
  • MilliporeSigma
  • PolyPlus Battery Company (PPBC)
  • Promega Corporation
  • Qiagen NV
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transfection Reagents and Equipment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Gene Therapy and Genetic Research
    • Technological Innovations in Transfection Methods
    • Expansion of Biotechnology and Pharmaceutical Industries
    • Increasing Investment in Cancer Research and Immunotherapy
    • Regulatory Approvals and Advancements in Clinical Applications
    • Growing Adoption of High-Throughput Screening
    • Market Demand for Efficient and Reliable Reagents
    • Impact of Personalized Medicine on Transfection Techniques
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Gene Expression Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Gene Expression Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Gene Expression Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Protein Production by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Transgenic Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Transgenic Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Transgenic Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Therapeutic Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Transfection Reagents and Equipment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Transfection Reagents and Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Transfection Reagents and Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Electroporation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Electroporation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Electroporation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Liposomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Particle Bombardment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Particle Bombardment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Particle Bombardment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Microinjection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Adenoviral Vectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Adenoviral Vectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Adenoviral Vectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Calcium Phosphate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Calcium Phosphate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Calcium Phosphate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: World 16-Year Perspective for Other Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • JAPAN
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • CHINA
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: China 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: China 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • EUROPE
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Transfection Reagents and Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Transfection Reagents and Equipment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • FRANCE
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: France 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: France 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • GERMANY
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: UK 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030

IV. COMPETITION